Sheng-Nan Cao (Shengnan Cao)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Spinal Cord Injury

Disease Activity

Epithelial Mesenchymal Transition

Top Venues

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Haojun Shi, Liangyu Xie, Wenchang Xu, Sheng-Nan Cao, Yuan-Zhen Chen
Nogo-A Is a Potential Prognostic Marker for Spinal Cord Injury. Disease markers 2022 (2022)
Sheng-Nan Cao, Guangjian Hou, Ya Meng, Yuan-Zhen Chen, Liangyu Xie, Bin Shi
Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury. Disease markers 2022 (2022)
Liang-Yu Xie, Sheng-Nan Cao, Zi-Teng Li, Dan-Dan Wang, Bin Shi
Effects of Fluid Shear Stress on Human Intervertebral Disc Nucleus Pulposus Cells Based on Label-Free Quantitative Proteomics. Disease markers 2022 (2022)
Yan Meng, Shifei Sun, Sheng-Nan Cao, Bin Shi
Netrin-1: A Serum Marker Predicting Cognitive Impairment after Spinal Cord Injury. Disease markers 2022 (2022)
Guodong Sun, Qingbo Wang, Sheng-Nan Cao, Haidong Xu, Yan Zhao
Governor Vessel Moxibustion Therapy Improves Microbiota Structure in Ankylosing Spondylitis Patients. Disease markers 2021 (2021)